Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference22 articles.
1. Primary brain tumours in adults;Behin;Lancet,2003
2. Problems of glioblastoma multiforme drug resistance;Stavrovskaya;Biochemistry (Mosc.),2016
3. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma;Fecci;Canc. Res.,2006
4. Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?;Heimberger;Neuro Oncol.,2011
5. Targeting immune checkpoints in malignant glioma;Zhang;Oncotarget,2017
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study;Signal Transduction and Targeted Therapy;2024-09-04
2. Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models;Cancers;2024-07-24
3. From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review;Journal of Experimental & Clinical Cancer Research;2024-02-12
4. Targeting MAGI2‐AS3‐modulated Akt‐dependent ATP‐binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide‐resistant glioblastoma cells;Drug Development Research;2023-08-08
5. Immunotherapy for Recurrent Glioma—From Bench to Bedside;Cancers;2023-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3